The FDA said Stryker had marketed devices without approval, and pointed out that the device manufacturer failed to notify the regulatory body of a product recall, according to the report. Stryker submitted a plan to correct the quality and recall issues.
More Articles on Supply Chain:
13 Recent Device Company Executive & Leadership Changes
NLT Spine Opens US Subsidiary
Alphatec Solus Fusion Device Receives FDA 510(k) Clearance
